Clin2
NCT06367465Possibly a fitRecruiting

Hepatitis C treatment during pregnancy

Hepatitis CPregnancy Complications

Treatments studied

Part of Digestive system, Infections, Women’s health & pregnancy clinical trials.

This study tests whether treating hepatitis C during pregnancy is feasible and acceptable for pregnant women who have a history of drug use. If you qualify, you may receive treatment that could help protect your health and your baby's health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are at least 18 years old.
  • You are currently pregnant.
  • You have been diagnosed with hepatitis C.
  • You have a history of past or current drug use.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07040319Recruiting· Phase 1/Phase 2
Hepatitis C treatment study for pregnant women

This study tests a medicine called glecaprevir/pibrentasvir for pregnant women with hepatitis C, with or without HIV. It aims to see how the medicine works in the body and if it is safe during pregnancy.

Los Angeles, California
NCT05368974Recruiting
Pregnancy registry for hepatitis C treatment timing

This study is a pregnancy registry that collects information about people who have hepatitis C during pregnancy and took hepatitis C medicines early in pregnancy. It aims to better understand the safety and outcomes of treatment around conception.

Atlanta, Georgia
NCT05248919Enrolling by invitation
Study treatment for hepatitis C that did not work before

This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.

Karachi, Sindh
NCT07054359Not yet recruiting
Hepatitis B treatment in pregnancy to prevent baby infection

This study compares two ways of treating hepatitis B in pregnant women to prevent passing the virus to their babies. It tests whether a standard universal treatment approach works better than a quick, point-of-care test-based strategy.

NCT07542951Enrolling by invitation· Phase 4
TAF vs TDF antiviral treatment during pregnancy for hepatitis B

This study compares two antiviral medications (TAF and TDF) in pregnant women with hepatitis B to see which is safer and more effective during pregnancy and for the baby's health.

Guangzhou, Guangdong
NCT05853718Recruiting· Phase 4
Tenofovir treatment for hepatitis B during pregnancy

This study tests tenofovir alafenamide (TAF) to lower hepatitis B in pregnant people and reduce the chance of passing it to the baby. You may be able to join if you’re pregnant with active hepatitis B and meet safety lab and pregnancy ultrasound requirements.

Hangzhou, Zhejiang

Hear when a new Hepatitis C trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.